FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
4C-ES CELL, MODELS 7547187, 7547188, 7547189, 7547190
K Number: K010064
·
Decision Feb 7, 2001
Classifications
1
FEI Numbers
32
Registration Numbers
32
Same Product Code
191
Applicant Total
270
Review Days
30
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- 4C-ES CELL, MODELS 7547187, 7547188, 7547189, 7547190
- K Number
- K010064
- Device Class
- FDA class 2
- Clearance Type
- Special
- Regulation Number
- 864.8625
- Medical Specialty
- Hematology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Beckman Coulter, Inc.
- Date Received
- January 8, 2001
- Decision Date
- February 7, 2001
- Product Code
- JPK
- Advisory Committee
- Hematology
- Review Advisory Committee
- HE
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| JPK | Mixture, Hematology Quality Control | FDA class 2 | Hematology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (JPK), ordered by most recent decision date.
XN CHECK BF
FDA 510(k)
FDA Class 2
·Hematology
XN-L CHECK
FDA 510(k)
FDA Class 2
·Hematology
XN CHECK
FDA 510(k)
FDA Class 2
·Hematology
BC-5D Hematology Control
FDA 510(k)
FDA Class 2
·Hematology
XN CHECK BF
FDA 510(k)
FDA Class 2
·Hematology
XN CHECK
FDA 510(k)
FDA Class 2
·Hematology
Other Clearances by Beckman Coulter, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K252169 | Access BNP II | Mar 24, 2026 | Substantially Equivalent |
| K254059 | Access anti-HBc IgM | Mar 13, 2026 | Substantially Equivalent |
| K253687 | Access anti-HBc Total | Feb 19, 2026 | Substantially Equivalent |
| K251995 | Access anti-HAV IgM | Jan 27, 2026 | Substantially Equivalent |
| K250588 | Access Rubella IgG | Nov 17, 2025 | Substantially Equivalent |
| K252580 | iQ200 Series | Sep 10, 2025 | Substantially Equivalent |
| K243846 | Access anti-HAV | Sep 9, 2025 | Substantially Equivalent |
| K243804 | MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) | Aug 20, 2025 | Substantially Equivalent |
| K250036 | MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL) | Aug 15, 2025 | Substantially Equivalent |
| K243483 | Access hsTnI | Aug 1, 2025 | Substantially Equivalent |